[HTML][HTML] Soft coral Lobophytum crassum extract inhibits migration and induces apoptosis capabilities in human oral squamous cell carcinoma cells

SM Wang, MC Lu, YM Hsu, CC Huang, CY Fang… - Journal of Dental …, 2024 - Elsevier
Background/purpose The extract of the soft coral Lobophytum crassum has shown an anti-
cancer activity in various cancer cells. However, its effect on the oral squamous cell …

[HTML][HTML] Prognostic factors on surgically and non-surgically treated oral squamous cell carcinoma: Advances in survival in fifteen years of follow up

TS Dantas, FB Sousa - Journal of Clinical and Experimental …, 2021 - ncbi.nlm.nih.gov
Prognostic factors on surgically and non-surgically treated oral squamous cell carcinoma:
Advances in survival in fifteen years of follow up - PMC Back to Top Skip to main content NIH …

Outcomes of salvage treatment in patients with recurrent oral squamous cell carcinoma

TC Chen, TH Lo, HC Huang, CW Wang, TL Yang… - Head & …, 2021 - Wiley Online Library
Background The survival outcomes of different salvage treatments for patients with recurrent
oral cancer remain unclear. Methods A total of 556 patients with recurrent oral cancer …

Novel Effective Therapeutic Regimen for Recurrent/Metastatic Head and Neck Squamous Cell Cancer: Concurrent Triple Oral Metronomic Chemotherapy and …

S Limaye, M Menon, S Singh… - Journal of …, 2024 - meridian.allenpress.com
METHODS Here, we report a retrospective case series of patients treated between 2017 and
2023 in the Division of Precision and Medical Oncology at Sir HN Reliance Foundation …

A comparison of two methods for the detection of circulating tumour cells in patients with oral cavity cancer

J Curtin, G Wong, W Wang, P Thomson… - Journal of Oral …, 2022 - Wiley Online Library
Abstract Background Circulating tumour cells (CTCs) detected in patient blood samples are
relevant as diagnostic and prognostic markers offering insights into tumour behaviour and …

The efficacy of low-dose immunotherapy in head-and-neck cancer

G Abraham, N Menon, VM Patil, AP Joshi… - Cancer Research …, 2019 - journals.lww.com
Immunotherapy has become the standard of care in many difficult to treat cancers over the
last decade. However, accessibility and cost limit its use in low‑and middle‑income countries …

Metronomic chemotherapy for scheduling oral cancer surgery during the COVID-19 pandemic

S Rajan, V Kumar, N Akhtar, S Gupta… - Indian Journal of …, 2020 - journals.lww.com
Worldwide, hospitals are facing problems in managing cancer patients during the ongoing
COVID-19 pandemic. Given the immense cancer burden of oral cancer in India, scheduling …

[PDF][PDF] The effectiveness and safety of metronomic chemotherapy in patients with head and neck carcinoma: a systematic review and meta-analysis

X Li, J Wang, T Zhang, J Wang, Z Zheng, C Wang… - 2021 - pdfs.semanticscholar.org
Background: Head and neck carcinoma, usually begins in the squamous cells, not only
seriously endangers the quality of life, but brings a heavy nancial burden for families and …

Clinical Benefits of Metronomic Chemotherapy in Platinum-Refractory, Recurrent, and Metastatic Head and Neck Squamous Cell Carcinoma

A Elwan, A Bakry, M Eesa, H Ismail… - Middle East Journal of …, 2024 - mejc.sums.ac.ir
Background: Patients with platinum-refractory disease who experience early treatment
failure of head and neck squamous cell carcinoma (HNSCC) exhibit a dismal prognosis …

[PDF][PDF] 安罗替尼的研究现状及其应用于晚期口腔鳞状细胞癌的治疗前景

楚晨, 孙艳, 尚伟, 张晓春, 葛胜优 - 中华口腔医学研究杂志(电子版), 2020 - zdkqyy.com
晚期口腔鳞状细胞癌(OSCC) 患者生存期短, 预后较差. 由于手术效果不佳, 耐药性,
不良反应等原因, 亟需更安全有效的新型化疗药物以提高晚期OSCC 患者生存质量 …